Risk factors for voriconazole-associated hepatotoxicity in patients with liver dysfunction: a retrospective nested case–control study
IntroductionVoriconazole is widely used to prevent and treat invasive aspergillosis. However, its use is restricted by adverse effects, including acute liver injury (ALI). Patients with hepatic insufficiency are often more susceptible to voriconazole-induced liver injury than those with normal hepat...
Saved in:
| Main Authors: | Jing Ren, Xinfeng Cai, Wei Ge, Jinlin Guo, Shan Wang, Qinhui Wang, Linna Liu, Le Yang, Qi Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1625003/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of pulmonary histoplasmosis treated with voriconazole
by: Congyi Xie, et al.
Published: (2022-03-01) -
CYP2C19‐Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients
by: Yoshiki Katada, et al.
Published: (2025-08-01) -
Efficacy and toxicity analysis of ganciclovir in patients with cytomegalovirus lung infection: what is new for target range of therapeutic drug monitoring
by: Dongjie Guo, et al.
Published: (2025-08-01) -
Evaluation of the Hepatotoxicity Induced by Captopril and Enalapril in Rat Liver: A Comparative Study
by: Mohammed Ibrahim, et al.
Published: (2023-12-01) -
Absolute purity determination of an organic fluorine pharmaceutical voriconazole via quantitative 19F NMR and method validation
by: Nahoko Uchiyama, et al.
Published: (2024-12-01)